Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,120.00
-2.00 (-0.18%)
Sep 29, 2026, 11:04 AM IDT
TLV:REKA Market Cap
TLV:REKA has a market cap or net worth of 128.07 million as of September 28, 2026. Its market cap has decreased by -0.44% in one year.
Market Cap
128.07M
Enterprise Value
243.31M
Revenue
304.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,120.00
ChartMarket Cap Chart
Since April 5, 2005, TLV:REKA's market cap has increased from 107.92M to 128.07M, an increase of 18.67%. That is a compound annual growth rate of 0.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 128.07M | 2.56% |
| Dec 31, 2025 | 124.88M | -17.43% |
| Dec 31, 2024 | 151.24M | -10.35% |
| Dec 31, 2023 | 168.71M | -3.96% |
| Dec 29, 2022 | 175.67M | -33.89% |
| Dec 30, 2021 | 265.73M | -13.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.55B |
| Amal Holdings A.D. | 2.28B |
| Rafa Laboratories | 1.78B |
| BrainsWay | 1.61B |
| Bonus BioGroup | 214.94M |
| InterCure | 198.77M |
| Golden House | 162.15M |
| Epitomee Medical | 118.26M |